Abstract
A novel one-pot four-component synthetic method for 3-(1,3,4-thiadiazol-2-ylamino)-3-arylpropanoates by condensation of 2-amino-1,3,4-thiadiazoles, aldehydes, Meldrums acid and aliphatic alcohols catalyzed by p-toluenesulfonic acid was described. The protocol has advantages of mild conditions, high yield and simple work-up procedure.
Keywords: β-Amino acid ester, condensation, four-component synthesis, Meldrum's acid, 1,3,4-thiadiazole, 3-(1,3,4-thiadiazol-2-ylamino)-3-arylpropanoate
Letters in Organic Chemistry
Title: One-Pot Four-Component Synthesis of 3-(1,3,4-Thiadiazol-2-ylamino)-3-arylpropanoates
Volume: 7 Issue: 6
Author(s): Zheng Li, Yanbo Li, Hongfang Cai, Jun Xu and Jinghong Shi
Affiliation:
Keywords: β-Amino acid ester, condensation, four-component synthesis, Meldrum's acid, 1,3,4-thiadiazole, 3-(1,3,4-thiadiazol-2-ylamino)-3-arylpropanoate
Abstract: A novel one-pot four-component synthetic method for 3-(1,3,4-thiadiazol-2-ylamino)-3-arylpropanoates by condensation of 2-amino-1,3,4-thiadiazoles, aldehydes, Meldrums acid and aliphatic alcohols catalyzed by p-toluenesulfonic acid was described. The protocol has advantages of mild conditions, high yield and simple work-up procedure.
Export Options
About this article
Cite this article as:
Li Zheng, Li Yanbo, Cai Hongfang, Xu Jun and Shi Jinghong, One-Pot Four-Component Synthesis of 3-(1,3,4-Thiadiazol-2-ylamino)-3-arylpropanoates, Letters in Organic Chemistry 2010; 7 (6) . https://dx.doi.org/10.2174/157017810791824964
DOI https://dx.doi.org/10.2174/157017810791824964 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Preface [Hot Topic: Multifaceted Treatment of Schizophrenia (Executive Editor: J. Ananth)]
Current Pharmaceutical Design 1,4-Benzothiazines-A Biologically Attractive Scaffold
Mini-Reviews in Medicinal Chemistry Epidemiology, Etiology, Screening, Psychotherapy of Malignant Tumor Patients with Secondary Depressive Disorder
Current Pharmaceutical Design Probing Cerebrovascular Alterations in Alzheimers Disease Using MRI: From Transgenic Models to Patients
Current Medical Imaging Receptor for AGEs (RAGE) as Mediator of NF-kB Pathway Activation in Neuroinflammation and Oxidative Stress
CNS & Neurological Disorders - Drug Targets What is Tobacco Smoke? Sociocultural Dimensions of the Association with Cardiovascular Risk
Current Pharmaceutical Design Preface
Current Neuropharmacology Developing Novel Therapeutic Approaches to Frailty
Current Pharmaceutical Design Pharmacological Evaluation of the Recuperative Effect of Morusin Against Aluminium Trichloride (AlCl3)-Induced Memory Impairment in Rats
Central Nervous System Agents in Medicinal Chemistry Design and Analysis of a Dual-Mode MEMS Micromirror
Micro and Nanosystems Molecular Biomarkers in Schizophrenia – Implications for Clinical Practice
Current Psychiatry Reviews When Ubiquitin Meets NF-κB: A Trove for Anti-cancer Drug Development
Current Pharmaceutical Design Delayed Neuroleptic Malignant Syndrome Associated with the Use of Low Dose Risperidone in Conjunction with Cholinergic Drugs-the Dangers of Polypharmacy in the Elderly
Current Drug Therapy Update on the Use of Biologics in Lupus
Current Pharmaceutical Biotechnology Molecular Chaperones as Rational Drug Targets for Parkinsons Disease Therapeutics
CNS & Neurological Disorders - Drug Targets Using Endogenous Neural Stem Cells to Enhance Recovery from Ischemic Brain Injury
Current Neurovascular Research Alzheimer’s Disease and Environmental Exposure to Lead: The Epidemiologic Evidence and Potential Role of Epigenetics
Current Alzheimer Research Hypotensive Effects of the Triterpene Oleanolic Acid for Cardiovascular Prevention
Current Molecular Pharmacology GABAergic Drugs for the Treatment of Migraine
CNS & Neurological Disorders - Drug Targets Processing of Amyloid Precursor Protein as a Biochemical Link Between Atherosclerosis and Alzheimers Disease
Cardiovascular & Hematological Disorders-Drug Targets